Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SRIKAR KARANAM

Allopathic & Osteopathic Physicians Emergency Medicine

NPI
1588034227
CMS profile
1358184
Location
APPLETON, WI

General Payments · PY2019–2024

$87,771.62

  • Reported across 44 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$50,969.38

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $50,960.00 23
Travel and Lodging $9.38 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $50,969.38 24

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $67.24 1
PY2022 $13,855.00 8
PY2023 $22,880.00 11
PY2024 $50,969.38 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137595550 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137595554 CMS
Takeda Pharmaceuticals U.S.A., Inc. $520.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 1137595557 CMS
Takeda Pharmaceuticals U.S.A., Inc. $9.38 02/09/2024 Travel and Lodging Undisputed 01/23/2026 1137595561 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137595565 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137595568 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137595572 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137595576 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137595579 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137595583 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137595587 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137595590 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137595594 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137595598 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137595601 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137595605 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137595609 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137595612 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137595616 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137595620 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137595624 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137595627 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,080.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137595631 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,600.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137595635 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.